retatrutide dosage clinical trials retatrutide trial dosing frequency microdosing: guide to split protocols and schedules The Chart: A – Retatrutide Dosing Guide: 1-12 mg

References Eli Lilly and Company

While the FDA requires pancreatitis warnings on these medications, the exact causal relationship remains unclear

In the Phase 2 trial protocol, participants began at a low starting dose commonly 2 mg once weekly before progressing through incremental increases over several months, with target maintenance doses ranging from 8 mg to 12 mg weekly depending on tolerability and clinical response

Tolerability is not a luxury

Figure 10: Diagram of the RIA method together with photographs of Professor Rosalyn Yalow (top) and Professor Solomon Berson (bottom)

Notably, the primary Phase 2 obesity trial enrolled participants largely without type 2 diabetes, so effects in people with diabetes may differ